Predicting tumor response and outcome of second-look surgery with (18)F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer

BACKGROUND: This ancillary study aimed to evaluate (18)F-FDG PET parameter changes after one cycle of treatment compared to baseline in patients receiving first-line neoadjuvant anti-angiogenic nintedanib combined to paclitaxel-carboplatin chemotherapy or chemotherapy plus placebo and to evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Aide, Nicolas, Fauchille, Pauline, Coquan, Elodie, Ferron, Gwenael, Combe, Pierre, Meunier, Jérome, Alexandre, Jerôme, Berton, Dominique, Leary, Alexandra, De Rauglaudre, Gaétan, Bonichon, Nathalie, Pujade Lauraine, Eric, Joly, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113167/
https://www.ncbi.nlm.nih.gov/pubmed/33221969
http://dx.doi.org/10.1007/s00259-020-05092-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113167/
https://www.ncbi.nlm.nih.gov/pubmed/33221969
http://dx.doi.org/10.1007/s00259-020-05092-3

Ejemplares similares